How can we live healthier for longer? 聽History shows that the answers lie in fundamental biology. Today, CSHL鈥檚 research in the interdisciplinary fields of brain- and whole-body physiology is setting the stage for improved cancer therapeutics and biomedical advances that will allow people to maintain their physical and mental health even as they enter the later stages of life.
CSHL President and CEO Bruce Stillman
In 1992, then-CSHL Fellow and future Nobel laureate Carol Grieder definitively linked the enzyme telomerase to cancer. Since then, CSHL scientists working on the cutting edge have continued to unravel the complex interactions between tumors, metabolism, the immune system, and the brain.
Recent studies have laid the groundwork for future therapeutics targeting a variety of age-related diseases.
Rockefeller University geneticist Jeffrey Friedman speaks about obesity鈥檚 causes and treatments at CSHL鈥檚 Brain-Body Physiology Symposium.
Learn More黑料吃瓜资源 scientists identified the first cancer-causing gene and completed the first genomic profile of multiple individual cancer cells within a single tumor. These breakthroughs鈥攖wo of鈥�
Learn More
Fundamental chemistry at CSHL helped revive a powerful antibiotic against drug-resistant bacteria, opening a new front in the fight against superbugs.
Read Story
Generations of scientific pioneers reflect on the discoveries, collaborations, and risks that have defined their careers.
Read Story
At the 32nd Annual CSHL Golf Tournament, a day of athleticism and camaraderie was also one of generosity.
Read StoryYour gift is more than a donation鈥攊t鈥檚 an investment in
discovery and in a future shaped by science.
The Simons
Foundation
The Mark Foundation
for Cancer Research